Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents

BACKGROUND: The emergence and spread of SARS-CoV-2 throughout the world has created an enormous socioeconomic impact. Although there are several promising drug candidates in clinical trials, none is available clinically. Thus, the drug repurposing approach may help to overcome the current pandemic....

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Mohammad Z., Zia, Qamar, Haque, Anzarul, Alqahtani, Ali S., Almarfadi, Omar M., Banawas, Saeed, Alqahtani, Mohammed S., Ameta, Keshav L., Haque, Shafiul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871101/
https://www.ncbi.nlm.nih.gov/pubmed/33866129
http://dx.doi.org/10.1016/j.jiph.2021.01.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871101/
https://www.ncbi.nlm.nih.gov/pubmed/33866129
http://dx.doi.org/10.1016/j.jiph.2021.01.016

Ejemplares similares